Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07195669) titled 'RCT: Suzetrigine vs Norco for Post-op Pain' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).
Primary Sponsor: Jacob Lensing
Condition:
Pain Control
Intervention:
Drug: Suzetrigine (SUZ)
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 1, 2025
Target Sample Size: 76
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07195669
Published by HT Digital Content Services with permis...